Phase I Two-Year Follow Up Study Results Released

In our Phase I two-year follow up study, our clinical team monitored the Phase I patients for two additional years after their treatment. Our results showed that there were no long-term side effects from the MSC-NP therapy. Importantly, a subset of patients showed sustained clinical improvement two years after treatment. These encouraging findings suggest that some of the clinical benefits of MSC-NP may be long-lasting.

CLICK HERE or the link below to read more:

https://tischms.org/phase-i-published-results-2-year-follow